Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
3.890
+0.150 (4.01%)
Mar 17, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Surgical Glaucoma
75.72M75.90M74.31M65.59M46.50M
Surgical Glaucoma Growth
-0.23%2.14%13.29%41.07%78.83%
Dry Eye
1.64M3.96M6.75M5.74M2.46M
Dry Eye Growth
-58.65%-41.24%17.59%133.21%50.00%
Total
77.36M79.87M81.06M71.33M48.96M
Total Growth
-3.13%-1.47%13.63%45.70%77.12%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
77.36M79.87M81.06M71.33M48.96M
United States Growth
-3.13%-1.47%13.63%45.70%77.12%
Total
77.36M79.87M81.06M71.33M48.96M
Total Growth
-3.13%-1.47%13.63%45.70%77.12%
Source: S&P Global Market Intelligence.